|
|
MUSC Psychiatry Chair Update
Thomas W. Uhde, M.D.
Department of Psychiatry and Behavioral Sciences
Institute of Psychiatry |
|
|---|
|
ONGOING STUDIES & PUBLICATIONS |
|
Research in the Department
Ranked 11th in the nation among departments of psychiatry in total research funding from the National Institutes of Health, MUSC Psychiatry is the single largest research department in the College of Medicine. |
|
|
|
|
| |
|
 |
Two MUSC professors are using neurotechnology to revolutionize meditation
An ancient practice is getting a modern-age boost thanks to two brain experts from the Medical University of South Carolina.
What started as a passion project for Dr. Bashar Badran, a neuroscientist, MUSC professor of psychiatry, and director of the Neuro-X Lab, and Dr. Baron Short, a physician dual trained in medicine and psychiatry, MUSC professor, and director of the MUSC Health Brain Stimulation Service turned into the development of a device that gives users the maximum benefits of meditation in just a fraction of the time.
It’s called Zendo and it uses an advanced technology called transcranial direct current stimulation (TDCS) to quickly give you the benefits of meditation by activating the meditation centers of your brain.
“TCDS actually delivers low levels of electricity to specific parts of your brain through your scalp and through your skull,” Badran explained. “So what we do at Zendo is create these custom, wearable pads that stick to two parts of your head, one over your left forehead and one over your right temple and that is a specific orientation to deliver electricity to the underlying brain targets that are involved in expert meditation practice.”
In addition to fostering a calm, mindful state in the practitioner, meditation is said to deliver a number of other physical and mental health benefits including improved memory, better sleep, reduced stress, lower blood pressure, lessened anxiety, and pain reduction.
|
|
|
|
|
Congratulations to Dr. Colleen Halliday who was recently funded by Patient-Centered Outcomes Research Institute (PCORI) as co-PI! Project information can be found here. |
|
|
|
|
Martha Gomez, LMSW was recognized on 12/2/21 with the Patricia Ravenhorst Trailblazer Award from the Immigrant Victims Council of SC. Martha was nominated by Drs. Alyssa Rheingold, Michael de Arellano, and Rosaura Orengo Aguayo, as well as Meg Wallace and Virginia Green for this award. She was nominated due to her work extensive work over the years for the Hispanic/Latinx community, particularly for victims of crime, as well as her work to ensure that COVID testing and vaccine information was disseminated easily to this population during the pandemic. Congratulations, Martha! |
|
|
|
|
The MUSC Pain Rehabilitation Program was selected as a site for the Biomarkers for Evaluating Spine Treatment (BEST) Trial!
This NIAMS-funded multi-site RCT, as part of the NIH Heal Initiative, will evaluate three different treatments for chronic low back pain (vs enhanced treatment as usual): Duloxetine, Acceptance and Commitment Therapy (ACT), and Exercise-based manual therapy (by PT). As part of biomarker development, there will also be brain/spine imaging and psychological phenotyping.
Our own Dr. Sharlene Wedin will be one of the ACT psychologists for the study, and we are very grateful to Dr. Borckardt and the MUSC Brain Stimulation Lab for assisting with the brain imaging component. We are also hopeful that Emily Scruggs, our phenomenal Pain Rehab PT, will be able to lead the PT arm of the study. Not many universities/hospitals can demonstrate the breadth of resources and skill needed to undertake a multidisciplinary trial like this.
We are excited about the potential for this study to change the paradigm for how we treat patients with low back pain, and we're very proud that MUSC is a part of the stellar group of sites/investigators in the BEST network. Aside from providing another option for our patients with chronic pain, this study will advance much-needed research in this area.
The trial should launch around March 2022 and we will reach out to our clinical colleagues at that time with referral information.
|
|
|---|
|
EMPLOYEE RECOGNITION PROGRAM |
|
Do you know an employee who has gone the extra mile recently? Nominate them for the Department of Psychiatry & Behavioral Sciences' MVP Award! This award will be given quarterly to an employee nominated by their peers for going above and beyond in the workplace. For more information or to nominate an employee, please visit our Employee Recognition Page on the Horseshoe. |
|
|---|
|
NATIONAL STATE OF EMERGENCY IN CHILDREN'S MENTAL HEALTH |
|
The American Academy of Pediatrics (AAP), the American Academy of Child and Adolescent Psychiatry (AACAP) and the Children’s Hospital Association (CHA) have joined together to declare a National State of Emergency in Children’s Mental Health.
To learn more about the worsening crisis in child and adolescent mental health, please refer to the declaration published by the American Academy of Pediatrics.
|
|
2021-2022 GRAND ROUND SERIES |
|
STAFF
Eligible full-time staff can carry up to 360 annual leave hours and 1,440 sick leave hours. The cutback leave date for staff is always December 31 each year.
Please reach out to your designated timekeeper if you are unsure of how much leave you have.
FACULTY
Due to the ongoing pandemic, MUSC Executive Leadership has extended the Faculty Annual Leave cutback date to December 31, 2021 (normally 6/30). Based on the December 31 faculty cutback extension, all unused annual leave in excess of 360 hours, regardless of future leave approvals in the Kronos system, will be cutback to 360 hours in January 2022.
We encourage you to review the annual leave balances for the faculty members in your areas and determine if you have individuals who stand to lose leave when the automatic reduction occurs, and if so, we ask that you share this information with them. We also ask that you update all leave records as necessary to ensure we have the correct leave balances on file before the automatic reduction occurs. Leave balances can be viewed directly using MyRecords, found on the Horseshoe under the Employee Corner, http://horseshoe.musc.edu/human-resources/univ/employee-corner.
If you have questions concerning annual leave cutbacks or accruals, please contact Monique Robinson at robinsmo@musc.edu or 843-792-7225. |
|
HOLLINGS CANCER CENTER
T32 ITOS FELLOWS APPLICATION |
|
STAR CHILDREN'S DAY TREATMENT PROGRAM |
|
SURVIVORS OF HOMICIDE
SUPPORT GROUP VIGIL |
|
SOCIETY FOR CLINICAL SOCIAL WORK
2022 ANNUAL CONFERENCE |
|
Child & Adolescent Division
Open Rank/Faculty (UNIV, Full-Time): This candidate will primarily provide inpatient services to children and adolescents (6-12yo) in the Institute of Psychiatry. They will be responsible for the care of patients and the supervision of medical students, residents, and Child Fellows for one of our interdisciplinary care teams. This candidate will also have a small portion of their effort dedicated to another service that may consist of telemedicine, outpatient care, and/or residential care depending on candidates preferences and effort availability.
Open Rank/Faculty (UNIV, Full-Time): This candidate will work as a consultant and liaison for the Shawn Jenkins Children’s Hospital + Pearl Tourville Women’s Health Pavilion providing psychiatric consultation and care to patients in inpatient and urgent care in that facility. This candidate will also supervise and provide education to C&A Fellows and other APPs who help staff this service. This candidate will also provide supervision for general residents and fellows in the Child and Adolescent Outpatient MUSC ED Walk in Clinic, helping to establish care for families who were recently seen in the MUSC Pediatric Emergency Room.
Assistant Professor (UNIV, Full-Time): The Medical University of South Carolina's (MUSC) Division of Child and Adolescent Psychiatry in the
Department of Psychiatry & Behavioral Sciences is recruiting for clinician-educator faculty positions in downtown Charleston, SC. According to the candidate’s preferences they may be involved with clinical services across a variety of clinical settings including outpatient, day treatment, inpatient and residential programs. Direct patient encounters and tele-psychiatry services may also be included. Desire to work with medical students, residents, and child fellows preferred.
|
|
Struggling with Depression?
We are currently seeking individuals between the ages of 21-70, diagnosed with Major Depressive Disorder (MDD) to participate in a research trial using repetitive transcranial magnetic stimulation (rTMS). Treatment and study related assessments will be provided at no charge.
|
|
|---|
|
SELF CARE SUPPORT SESSIONS |
|
COMPREHENSIVE PSYCHIATRIC
CARE SPECIALISTS (CPCS) |
|
| The CPCS office is currently taking referrals for youth and adults for outpatient therapy and/or medication management. |
|
|
The CPCS office is located at 26 Bee Street and is seeing patients either virtually or in the office. All patients are self-pay at the time of the appointment and will be provided with the necessary paperwork to submit for reimbursement from their insurance companies. All department of psychiatry faculty members are eligible to see private patients in CPCS.
To make a referral or schedule an appointment, call 843-792-9396.
For more information about making a referral or joining the practice, feel free to contact Hilary Bernstein, LISW, DHA at bernsteh@musc.edu
Check out our website: Psychiatriccarespecialists.com
Like our Facebook page: Comprehensive Psychiatric Care Specialists
|
|
|
|
|
|
FENTANYL URINE TEST
CLINICAL NEUROBIOLOGY LAB |
|
FENTANYL URINE TEST NOW OFFERED BY
THE CLINICAL NEUROBIOLOGY LAB (CNL)
The use of the powerful opiate drug, FENTANYL is on the rise, accounting for a large share of overdose deaths in SC, and the greater US.
Previously, urine drug testing at MUSC could not detect Fentanyl use. The Clinical Neurobiology Laboratory has recently completed an extensive validation of a qualitative (positive vs negative) urine test for the presence of Fentanyl which can be used to distinguish this drug from other commonly used/abused opiates such as oxycodone, buprenorphine and morphine. This test should aid clinicians in the evaluation of patients in multiple clinical settings, especially when illicit drug use is suspected.
Simply order: “Fentanyl, Urine, Qual (IOP LAB)” or “LAB9066”
|
|
|
|
|
Individuals needing to contact the MUSC COVID Vaccine Call Center can utilize the information below:
|
|
|---|
|
The COVID-19 Vaccine Task Force will be posting updates on the COVID-19 Vaccine intranet site, including information about the vaccine safety and efficacy, so our care team members can make an informed decision.
**Updated University Directives can be found here.**
|
|
|---|
|
LAB & TESTING OPTIONS
The following resource provides MUSC Health lab and testing options pertaining to COVID-19. Included on this page is information regarding drive-thru and “pop-up” mobile COVID testing locations, antibody or serology tests, drive-in lab and nurse visits, and original/classic lab testing.
MUSC Health Lab & Testing Options
|
|
|
MANDATORY SELF-MONITORING
Due to the activity of COVID-19 within the hospital and community, all employees, residents, fellows and students within all MUSC entities are directed to begin daily self-monitoring for COVID-19 symptoms. This applies regardless of whether you have been working remotely on a full-time or intermittent basis.
You need to continue daily self-monitoring, even if symptoms are not present.
|
|
|---|
|
UPDATES VIA THE HORSESHOE
In addition to updates provided by MUSC Enterprise, the Department of Psychiatry and Behavioral Sciences will also provide updates through our employee intranet, The Horseshoe. Updates will be provided regularly as new information becomes available. For your convenience, direct links are provided below.
|
|
|---|
|
NAMI CONNECTION & NAMI FAMILY SUPPORT |
|
UPDATED MOONLIGHTING POLICY |
|
THANK YOU TO OUR SUPPORTERS |
|
If you would like to submit content to include in next week's Chair Update, please submit to Dr. Jamie Fisher by 12:00 pm on Monday. Thank you. |
|
|---|
|
|
|
| | |
|  |
|
|
|
|
